with remestemcel appearing to reduce ICU timeframes and improving survival rates, the US can now get back to their herd experiment.
One further note: This was administered very late stage, imagine if if was given much earlier, probably the survival rates could be even higher..,
- Forums
- ASX - By Stock
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
with remestemcel appearing to reduce ICU timeframes and...
-
- There are more pages in this discussion • 749 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.000(0.00%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2263 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.43 | 6118 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 225 | 1.545 |
3 | 2263 | 1.530 |
4 | 5656 | 1.515 |
4 | 16797 | 1.510 |
2 | 3000 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.430 | 6118 | 1 |
1.460 | 11902 | 5 |
1.465 | 14000 | 1 |
1.470 | 23822 | 2 |
1.475 | 714 | 1 |
Last trade - 09.59am 12/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online